Variation Biotechnologies Inc.
22 de Varennes, Suite 210
7 articles with Variation Biotechnologies Inc.
8/6/2020Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.
VBI Vaccines Awarded Up to CAD$56 Million Contribution from Canadian Government to Accelerate Coronavirus Vaccine Development
- Government of Canada will support advancement of VBI’s coronavirus program through Phase 2 clinical development - Pre-clinical data are expected to enable selection of clinical candidates in Q3 2020 and the initiation of clinical studies by the end of 2020
Variation Biotechnologies Inc. to Present Positive Influenza Vaccine Data at the 49th Annual ICAAC Meeting
Burns & Levinson's Canadian Subsidiary Helps Variation Biotechnologies Inc. Land More Than $35 Million In Venture Capital Funding